Xiaoyan Zhao

No. 1095, Jiefang Avenue
Wuhan, 430000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Circadian rhythm-guided cellular therapy in hematologic malignancies: mechanisms, clinical evidence, and optimization strategies.

Circadian rhythm-guided cellular therapy in hematologic malignancies: mechanisms, clinical evidence, and optimization strategies.

Journal: Biomarker research

Published: April 09, 2026

PRMT7-mediated arginine methylation of FOXK activates Wnt/β-catenin signalling to drive doxorubicin resistance in diffuse large B-cell lymphoma.

PRMT7-mediated arginine methylation of FOXK activates Wnt/β-catenin signalling to drive doxorubicin resistance in diffuse large B-cell lymphoma.

Journal: Clinical and translational medicine

Published: March 18, 2026

A prospective, open, single-arm clinical trial of fludarabine- cyclophosphamide-porcine anti-lymphocyte globulin conditioning combined with matched sibling donor hematopoietic stem cell transplantation in the treatment of severe aplastic anemia.

A prospective, open, single-arm clinical trial of fludarabine- cyclophosphamide-porcine anti-lymphocyte globulin conditioning combined with matched sibling donor hematopoietic stem cell transplantation in the treatment of severe aplastic anemia.

Journal: Clinical and experimental medicine

Published: September 24, 2025

Targeting N-Cadherin and Tubulin α 1A in Neuroblastoma Bone Marrow Metastasis: Insights from Single-Cell Analysis and Drug Screening.

Targeting N-Cadherin and Tubulin α 1A in Neuroblastoma Bone Marrow Metastasis: Insights from Single-Cell Analysis and Drug Screening.

Journal: The American journal of pathology

Published: August 05, 2025

A Novel Modified Bu/Vp16/cy/Flu/Ara-C Conditioning Regimen Enhances Outcomes for High-Risk Acute Lymphoblastic Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

A Novel Modified Bu/Vp16/cy/Flu/Ara-C Conditioning Regimen Enhances Outcomes for High-Risk Acute Lymphoblastic Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Cancer medicine

Published: July 05, 2025

CAR-exosomes derived from immune cells: an emerging nanoscale vanguard in overcoming tumor immunotherapy hurdles.

CAR-exosomes derived from immune cells: an emerging nanoscale vanguard in overcoming tumor immunotherapy hurdles.

Journal: Frontiers in immunology

Published: June 27, 2025

Increased TIGIT expression correlates with impaired NK cell function in diffuse large B-cell lymphoma.

Increased TIGIT expression correlates with impaired NK cell function in diffuse large B-cell lymphoma.

Journal: Frontiers in oncology

Published: December 24, 2024

Identification of Crucial Genes Associated With MYCN-Driven Neuroblastoma Based on Single-Cell Analysis and Machine Learning.

Identification of Crucial Genes Associated With MYCN-Driven Neuroblastoma Based on Single-Cell Analysis and Machine Learning.

Journal: Cancer medicine

Published: November 22, 2024

Effectiveness of in vivo T-cell-depleted regimen containing porcine anti-lymphocyte globulin or rabbit anti-thymocyte globulin in preventing acute graft-versus-host disease after haploidentical haematopoietic stem cell transplantation.

Effectiveness of in vivo T-cell-depleted regimen containing porcine anti-lymphocyte globulin or rabbit anti-thymocyte globulin in preventing acute graft-versus-host disease after haploidentical haematopoietic stem cell transplantation.

Journal: British journal of haematology

Published: August 29, 2023

Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre-transplant minimal residual disease on outcomes in high-risk acute lymphoblastic leukemia patients in complete remission.

Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre-transplant minimal residual disease on outcomes in high-risk acute lymphoblastic leukemia patients in complete remission.

Journal: Cancer medicine

Published: August 17, 2023

MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression.

MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression.

Journal: The EMBO journal

Published: May 19, 2023

Discrepancy between two invasive blood pressure measurements in patients receiving intra-aortic balloon pump therapy.

Discrepancy between two invasive blood pressure measurements in patients receiving intra-aortic balloon pump therapy.

Journal: BMC cardiovascular disorders

Published: April 18, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026